Hikal Ltd.

₹398.45

Hikal Ltd.

₹398.45

₹398.45

8.25 (2.11%) - 8 Apr 2025 04:26 PM

About Company

Hikal Limited offers solutions across the life sciences value chain. The company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The company provides world-class active ingredients, intermediates and R&D services to global pharmaceuticals, animal health, biotech, crop protection and specialty chemicals companies.

Market Cap. ₹4,811 Cr.
52 Week - High/Low ₹465/267
P/E Ratio 64.60
P/B Ratio 4.05
Enterprise Value ₹5,333 Cr.
ROE % 5.99
RSI Value 49.23
EMA 50 383.65
EMA 200 363.27
Net Profit 70 Cr.
Net Profit 3year growth -47.79 Cr.
Net Profit 3 year (back) 133 Cr.
Debt to Equity 0.69 %
EPS Growth TTM 3.6 %
Current Ratio 1.28 %
100 Day SMA 382 Rs.
200 Day SMA 367 Rs.
21 Day SMA 398 Rs.
50 Day SMA 372 Rs.
Book Value 96 Rs.
EV/EBITDA Ratio 18
QoQ EPS Growth -4 %
QoQ Operating Profit Growth -3 %
QoQ Sales Growth -1 %
Sales Latest Quarter 439 Cr.
YoY Sales Growth 0 %
Market Cap. ₹4,811 Cr.
52 Week - High/Low ₹465/267
P/E Ratio 64.60
P/B Ratio 4.05
Enterprise Value ₹5,333 Cr.
ROE % 6.0
RSI Value 49.23
EMA 50 383.65
EMA 200 363.27
Net Profit 70 Cr.
Net Profit 3year growth 2.33 Cr.
Net Profit 3 year (back) 133 Cr.
Debt to Equity 0.69 %
EPS Growth TTM 3.96 %
Current Ratio 1.28 %
100 Day SMA 382 Rs.
200 Day SMA 367 Rs.
21 Day SMA 398 Rs.
50 Day SMA 372 Rs.
Book Value 96 Rs.
EV/EBITDA Ratio 18
QoQ EPS Growth -6 %
QoQ Operating Profit Growth -4 %
QoQ Sales Growth -1 %
Sales Latest Quarter 439 Cr.
YoY Sales Growth 0 %

Growth

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.